| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Discovery | 3 | 2022 | 94 | 1.130 |
Why?
|
| Small Molecule Libraries | 4 | 2021 | 53 | 0.840 |
Why?
|
| Molecular Docking Simulation | 7 | 2022 | 78 | 0.830 |
Why?
|
| Mitochondria | 7 | 2022 | 643 | 0.830 |
Why?
|
| Enzyme Inhibitors | 6 | 2012 | 659 | 0.710 |
Why?
|
| Alkyl and Aryl Transferases | 4 | 2009 | 9 | 0.710 |
Why?
|
| Antineoplastic Agents | 7 | 2022 | 1070 | 0.660 |
Why?
|
| Arrestins | 4 | 2016 | 92 | 0.660 |
Why?
|
| Signal Transduction | 13 | 2017 | 2689 | 0.660 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2017 | 167 | 0.640 |
Why?
|
| Frizzled Receptors | 1 | 2017 | 8 | 0.600 |
Why?
|
| NFATC Transcription Factors | 1 | 2017 | 40 | 0.590 |
Why?
|
| Arrestin | 1 | 2017 | 12 | 0.590 |
Why?
|
| Histone Deacetylase Inhibitors | 4 | 2020 | 116 | 0.570 |
Why?
|
| Membrane Proteins | 2 | 2019 | 617 | 0.560 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 164 | 0.540 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 2 | 2013 | 17 | 0.540 |
Why?
|
| Models, Molecular | 10 | 2017 | 546 | 0.490 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 2 | 2014 | 47 | 0.480 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2014 | 15 | 0.460 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2013 | 7 | 0.440 |
Why?
|
| Time-Lapse Imaging | 1 | 2013 | 8 | 0.440 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2013 | 27 | 0.440 |
Why?
|
| Carcinoma | 1 | 2014 | 215 | 0.410 |
Why?
|
| Ovarian Neoplasms | 1 | 2014 | 267 | 0.400 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 261 | 0.400 |
Why?
|
| Protein Binding | 9 | 2019 | 1027 | 0.390 |
Why?
|
| Biomarkers, Tumor | 2 | 2018 | 508 | 0.380 |
Why?
|
| Animals | 31 | 2022 | 20881 | 0.370 |
Why?
|
| Quantitative Structure-Activity Relationship | 2 | 2011 | 16 | 0.370 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2010 | 137 | 0.350 |
Why?
|
| Cell Line | 6 | 2018 | 1752 | 0.340 |
Why?
|
| RNA, Messenger | 1 | 2014 | 1664 | 0.340 |
Why?
|
| Aniline Compounds | 3 | 2020 | 52 | 0.320 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2020 | 116 | 0.290 |
Why?
|
| HEK293 Cells | 7 | 2018 | 326 | 0.290 |
Why?
|
| beta-Arrestins | 3 | 2017 | 80 | 0.290 |
Why?
|
| Ceramides | 3 | 2018 | 578 | 0.280 |
Why?
|
| GTP-Binding Proteins | 3 | 2013 | 231 | 0.270 |
Why?
|
| Humans | 31 | 2022 | 68618 | 0.270 |
Why?
|
| Cell Line, Tumor | 10 | 2022 | 1851 | 0.270 |
Why?
|
| Protein Phosphatase 2 | 2 | 2019 | 67 | 0.270 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2018 | 30 | 0.270 |
Why?
|
| Molecular Structure | 3 | 2016 | 397 | 0.240 |
Why?
|
| Lung Neoplasms | 3 | 2020 | 1173 | 0.240 |
Why?
|
| Mice | 12 | 2022 | 8474 | 0.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 756 | 0.230 |
Why?
|
| Cells, Cultured | 5 | 2017 | 2673 | 0.220 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2016 | 1745 | 0.220 |
Why?
|
| Apoptosis | 4 | 2019 | 1641 | 0.220 |
Why?
|
| Calcium | 3 | 2017 | 929 | 0.210 |
Why?
|
| High-Throughput Screening Assays | 2 | 2013 | 48 | 0.210 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2022 | 39 | 0.210 |
Why?
|
| Histone Demethylases | 1 | 2022 | 22 | 0.210 |
Why?
|
| Spermine | 1 | 2022 | 49 | 0.210 |
Why?
|
| Inflammasomes | 1 | 2022 | 39 | 0.210 |
Why?
|
| Structure-Activity Relationship | 4 | 2018 | 420 | 0.200 |
Why?
|
| Sphingosine | 2 | 2015 | 315 | 0.200 |
Why?
|
| Neuroblastoma | 1 | 2022 | 109 | 0.200 |
Why?
|
| NAD | 1 | 2022 | 73 | 0.200 |
Why?
|
| Fingolimod Hydrochloride | 2 | 2019 | 24 | 0.190 |
Why?
|
| Retinitis Pigmentosa | 1 | 2021 | 17 | 0.190 |
Why?
|
| Carboxylic Ester Hydrolases | 2 | 2011 | 26 | 0.190 |
Why?
|
| Protective Agents | 1 | 2021 | 36 | 0.190 |
Why?
|
| Cell Membrane | 3 | 2018 | 525 | 0.180 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2021 | 74 | 0.180 |
Why?
|
| Acrylamides | 1 | 2020 | 12 | 0.180 |
Why?
|
| Kinetics | 5 | 2018 | 1047 | 0.180 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2020 | 21 | 0.180 |
Why?
|
| Neuropilin-2 | 1 | 2020 | 19 | 0.180 |
Why?
|
| Necrosis | 2 | 2018 | 239 | 0.180 |
Why?
|
| Retinal Degeneration | 1 | 2021 | 75 | 0.180 |
Why?
|
| Racism | 1 | 2021 | 59 | 0.170 |
Why?
|
| Organelle Biogenesis | 2 | 2017 | 34 | 0.170 |
Why?
|
| Formoterol Fumarate | 2 | 2017 | 25 | 0.170 |
Why?
|
| Hemangiosarcoma | 1 | 2019 | 23 | 0.170 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2019 | 41 | 0.170 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2019 | 33 | 0.160 |
Why?
|
| Melanoma | 1 | 2022 | 335 | 0.160 |
Why?
|
| Histone Deacetylases | 2 | 2017 | 99 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2018 | 6 | 0.160 |
Why?
|
| Molecular Motor Proteins | 1 | 2018 | 14 | 0.160 |
Why?
|
| Myosin Heavy Chains | 1 | 2018 | 49 | 0.160 |
Why?
|
| Oxygen Consumption | 3 | 2017 | 258 | 0.160 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2019 | 151 | 0.160 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 231 | 0.160 |
Why?
|
| Cell Movement | 2 | 2020 | 630 | 0.160 |
Why?
|
| Neovascularization, Pathologic | 1 | 2019 | 183 | 0.160 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 334 | 0.150 |
Why?
|
| Genes, p53 | 1 | 2018 | 41 | 0.150 |
Why?
|
| Histone Deacetylase 1 | 1 | 2018 | 32 | 0.150 |
Why?
|
| F-Box Proteins | 1 | 2017 | 14 | 0.150 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 332 | 0.150 |
Why?
|
| Clenbuterol | 1 | 2017 | 9 | 0.150 |
Why?
|
| Structural Homology, Protein | 1 | 2017 | 16 | 0.150 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2018 | 110 | 0.150 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 346 | 0.150 |
Why?
|
| Intracellular Space | 1 | 2017 | 42 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 331 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2018 | 219 | 0.150 |
Why?
|
| Leukemia | 1 | 2018 | 117 | 0.150 |
Why?
|
| Amino Acid Motifs | 4 | 2006 | 77 | 0.150 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2017 | 81 | 0.150 |
Why?
|
| Carrier Proteins | 4 | 2004 | 597 | 0.150 |
Why?
|
| Kidney Neoplasms | 1 | 2018 | 206 | 0.140 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 300 | 0.140 |
Why?
|
| Hydrazones | 1 | 2016 | 11 | 0.140 |
Why?
|
| Zinc | 1 | 2017 | 73 | 0.140 |
Why?
|
| Phosphorylation | 6 | 2020 | 1200 | 0.140 |
Why?
|
| Computing Methodologies | 1 | 2016 | 2 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2017 | 235 | 0.130 |
Why?
|
| Peptides | 2 | 2014 | 455 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 507 | 0.130 |
Why?
|
| Drug Design | 3 | 2020 | 107 | 0.130 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 215 | 0.130 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2015 | 20 | 0.130 |
Why?
|
| A549 Cells | 3 | 2020 | 50 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 284 | 0.120 |
Why?
|
| Telomerase | 1 | 2015 | 85 | 0.120 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2014 | 93 | 0.120 |
Why?
|
| Dimerization | 3 | 2019 | 99 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2017 | 384 | 0.120 |
Why?
|
| Cell Nucleus | 1 | 2015 | 305 | 0.120 |
Why?
|
| Lysophospholipids | 1 | 2015 | 209 | 0.110 |
Why?
|
| Databases, Genetic | 1 | 2014 | 52 | 0.110 |
Why?
|
| Phenotype | 2 | 2014 | 947 | 0.110 |
Why?
|
| Amino Acid Sequence | 5 | 2017 | 1083 | 0.110 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 2550 | 0.110 |
Why?
|
| Data Mining | 1 | 2014 | 45 | 0.110 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 2 | 2003 | 31 | 0.110 |
Why?
|
| Mutation | 1 | 2018 | 1213 | 0.110 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 94 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 209 | 0.110 |
Why?
|
| Protein Prenylation | 3 | 2008 | 7 | 0.110 |
Why?
|
| Histone Chaperones | 1 | 2012 | 11 | 0.110 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2013 | 80 | 0.110 |
Why?
|
| Artificial Intelligence | 1 | 2014 | 159 | 0.110 |
Why?
|
| Propylene Glycols | 1 | 2012 | 16 | 0.110 |
Why?
|
| Automation | 1 | 2013 | 45 | 0.110 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2013 | 75 | 0.110 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 307 | 0.110 |
Why?
|
| Drug Interactions | 2 | 2011 | 289 | 0.110 |
Why?
|
| Boron Compounds | 1 | 2012 | 21 | 0.110 |
Why?
|
| Phagosomes | 1 | 2012 | 19 | 0.110 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 333 | 0.110 |
Why?
|
| Penicillin-Binding Proteins | 1 | 2012 | 15 | 0.110 |
Why?
|
| Penicillins | 1 | 2012 | 32 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 320 | 0.100 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2012 | 35 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 629 | 0.100 |
Why?
|
| Biological Assay | 1 | 2013 | 88 | 0.100 |
Why?
|
| Transcriptome | 1 | 2014 | 164 | 0.100 |
Why?
|
| Cyclic AMP | 1 | 2013 | 223 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2014 | 447 | 0.100 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2012 | 111 | 0.100 |
Why?
|
| Ethanolamines | 1 | 2012 | 33 | 0.100 |
Why?
|
| Angiotensin II | 1 | 2013 | 220 | 0.100 |
Why?
|
| Ion Channels | 1 | 2012 | 72 | 0.100 |
Why?
|
| Peptide Fragments | 2 | 2013 | 483 | 0.100 |
Why?
|
| Head and Neck Neoplasms | 1 | 2017 | 561 | 0.100 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2012 | 92 | 0.100 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2012 | 153 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2012 | 174 | 0.100 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 778 | 0.100 |
Why?
|
| Protease Inhibitors | 1 | 2011 | 76 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 498 | 0.100 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 800 | 0.100 |
Why?
|
| Environmental Pollutants | 1 | 2013 | 180 | 0.100 |
Why?
|
| Isoenzymes | 1 | 2012 | 308 | 0.100 |
Why?
|
| Female | 7 | 2019 | 38074 | 0.090 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2012 | 201 | 0.090 |
Why?
|
| Cell Respiration | 3 | 2017 | 47 | 0.090 |
Why?
|
| Cell Proliferation | 3 | 2020 | 1174 | 0.090 |
Why?
|
| Autophagy | 1 | 2012 | 208 | 0.090 |
Why?
|
| Bacterial Proteins | 1 | 2012 | 245 | 0.090 |
Why?
|
| Protein Methyltransferases | 2 | 2007 | 5 | 0.090 |
Why?
|
| Rats | 8 | 2016 | 5300 | 0.090 |
Why?
|
| Pyridines | 2 | 2011 | 261 | 0.090 |
Why?
|
| Rabbits | 3 | 2017 | 509 | 0.090 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2009 | 25 | 0.090 |
Why?
|
| Antiviral Agents | 1 | 2011 | 211 | 0.090 |
Why?
|
| Lipids | 2 | 2012 | 298 | 0.080 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 3 | 2006 | 35 | 0.080 |
Why?
|
| Ligands | 3 | 2016 | 317 | 0.080 |
Why?
|
| Molecular Sequence Data | 4 | 2006 | 1447 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2012 | 753 | 0.080 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2010 | 148 | 0.080 |
Why?
|
| Trabecular Meshwork | 1 | 2008 | 22 | 0.080 |
Why?
|
| Protein Conformation | 2 | 2016 | 362 | 0.080 |
Why?
|
| Aqueous Humor | 1 | 2008 | 51 | 0.080 |
Why?
|
| Cell Survival | 3 | 2016 | 901 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 1536 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2019 | 852 | 0.070 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2006 | 8 | 0.070 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2006 | 7 | 0.070 |
Why?
|
| Hydrolysis | 2 | 2010 | 144 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2020 | 331 | 0.070 |
Why?
|
| Pyrazoles | 1 | 2008 | 190 | 0.070 |
Why?
|
| Sesquiterpenes | 1 | 2006 | 41 | 0.070 |
Why?
|
| Enzyme Activation | 2 | 2020 | 791 | 0.070 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2006 | 4 | 0.070 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2006 | 10 | 0.070 |
Why?
|
| Allosteric Regulation | 2 | 2016 | 58 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 1026 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 304 | 0.060 |
Why?
|
| Dogs | 1 | 2006 | 490 | 0.060 |
Why?
|
| Substrate Specificity | 2 | 2017 | 234 | 0.060 |
Why?
|
| Glutathione Transferase | 2 | 2003 | 166 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2003 | 376 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 2077 | 0.060 |
Why?
|
| Guanosine Diphosphate | 1 | 2003 | 12 | 0.060 |
Why?
|
| Electron Transport | 2 | 2014 | 37 | 0.060 |
Why?
|
| GTP-Binding Protein Regulators | 1 | 2003 | 8 | 0.060 |
Why?
|
| Spindle Apparatus | 1 | 2003 | 13 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2015 | 238 | 0.060 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2003 | 21 | 0.060 |
Why?
|
| Algorithms | 1 | 2009 | 1196 | 0.060 |
Why?
|
| Caenorhabditis elegans | 1 | 2003 | 38 | 0.060 |
Why?
|
| Receptors, Serotonin | 1 | 2003 | 74 | 0.050 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 2 | 2013 | 14 | 0.050 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2022 | 6 | 0.050 |
Why?
|
| Flavins | 1 | 2022 | 5 | 0.050 |
Why?
|
| Acrolein | 1 | 2022 | 9 | 0.050 |
Why?
|
| Spermidine | 1 | 2022 | 21 | 0.050 |
Why?
|
| Benzoates | 1 | 2022 | 20 | 0.050 |
Why?
|
| Catalytic Domain | 2 | 2012 | 99 | 0.050 |
Why?
|
| Polyamines | 1 | 2022 | 79 | 0.050 |
Why?
|
| Cell Division | 1 | 2003 | 541 | 0.050 |
Why?
|
| Insecta | 1 | 2001 | 11 | 0.050 |
Why?
|
| Voltage-Dependent Anion Channels | 1 | 2022 | 40 | 0.050 |
Why?
|
| Recombinant Proteins | 3 | 2012 | 742 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2001 | 73 | 0.050 |
Why?
|
| Alanine | 1 | 2001 | 38 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2022 | 168 | 0.050 |
Why?
|
| Magnesium | 1 | 2001 | 110 | 0.050 |
Why?
|
| Amino Acids | 1 | 2001 | 131 | 0.050 |
Why?
|
| RNA Interference | 2 | 2017 | 266 | 0.050 |
Why?
|
| Transfection | 3 | 2013 | 782 | 0.050 |
Why?
|
| Sulfonamides | 2 | 2012 | 141 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 322 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 314 | 0.050 |
Why?
|
| Male | 7 | 2020 | 37321 | 0.050 |
Why?
|
| Behavior, Addictive | 1 | 2004 | 317 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2020 | 57 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 532 | 0.040 |
Why?
|
| Proteolysis | 1 | 2020 | 97 | 0.040 |
Why?
|
| Piperazines | 2 | 2012 | 206 | 0.040 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 108 | 0.040 |
Why?
|
| Oogenesis | 1 | 2018 | 10 | 0.040 |
Why?
|
| Cocaine-Related Disorders | 1 | 2004 | 504 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 369 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2019 | 294 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 2791 | 0.040 |
Why?
|
| Students | 1 | 2021 | 233 | 0.040 |
Why?
|
| CD13 Antigens | 1 | 2018 | 5 | 0.040 |
Why?
|
| Ovary | 1 | 2018 | 99 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2018 | 37 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2018 | 80 | 0.040 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2018 | 59 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2017 | 65 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2013 | 2083 | 0.040 |
Why?
|
| Protein Domains | 1 | 2017 | 74 | 0.040 |
Why?
|
| Esterases | 1 | 2017 | 9 | 0.040 |
Why?
|
| Cyclic GMP | 1 | 2017 | 99 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2017 | 231 | 0.040 |
Why?
|
| HMGB1 Protein | 1 | 2017 | 23 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2017 | 128 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2018 | 233 | 0.040 |
Why?
|
| Endopeptidases | 2 | 2007 | 52 | 0.040 |
Why?
|
| Lysine | 1 | 2017 | 96 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2017 | 223 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 445 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2016 | 237 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2016 | 124 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 1056 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2016 | 150 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2016 | 147 | 0.030 |
Why?
|
| Protein Transport | 1 | 2016 | 280 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2017 | 432 | 0.030 |
Why?
|
| tert-Butylhydroperoxide | 1 | 2014 | 14 | 0.030 |
Why?
|
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2014 | 11 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2017 | 431 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 1033 | 0.030 |
Why?
|
| Oxidants | 1 | 2014 | 48 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2014 | 72 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2018 | 1738 | 0.030 |
Why?
|
| COS Cells | 2 | 2006 | 155 | 0.030 |
Why?
|
| Proton Ionophores | 1 | 2013 | 7 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2003 | 28 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 2093 | 0.030 |
Why?
|
| Macrophages | 1 | 2017 | 647 | 0.030 |
Why?
|
| Losartan | 1 | 2013 | 45 | 0.030 |
Why?
|
| Allosteric Site | 1 | 2013 | 17 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2013 | 56 | 0.030 |
Why?
|
| Cell Polarity | 2 | 2003 | 49 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2014 | 215 | 0.030 |
Why?
|
| Protein Subunits | 2 | 2003 | 99 | 0.030 |
Why?
|
| Fluorescence Polarization | 1 | 2012 | 14 | 0.030 |
Why?
|
| beta-Lactam Resistance | 1 | 2012 | 6 | 0.030 |
Why?
|
| Luciferases | 1 | 2013 | 105 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2013 | 191 | 0.030 |
Why?
|
| Nitrophenols | 1 | 2012 | 14 | 0.030 |
Why?
|
| Cephalosporins | 1 | 2012 | 59 | 0.030 |
Why?
|
| Cytochromes c | 1 | 2012 | 75 | 0.030 |
Why?
|
| Fluoxetine | 1 | 2012 | 40 | 0.030 |
Why?
|
| Saquinavir | 1 | 2011 | 1 | 0.030 |
Why?
|
| Nelfinavir | 1 | 2011 | 4 | 0.030 |
Why?
|
| Atazanavir Sulfate | 1 | 2011 | 6 | 0.030 |
Why?
|
| Isoproterenol | 1 | 2012 | 163 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 196 | 0.030 |
Why?
|
| Bias | 1 | 2013 | 148 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 3259 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2012 | 226 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 144 | 0.030 |
Why?
|
| Caspases | 1 | 2012 | 194 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 175 | 0.020 |
Why?
|
| Ritonavir | 1 | 2011 | 18 | 0.020 |
Why?
|
| Bone Density | 1 | 2013 | 159 | 0.020 |
Why?
|
| Kallikreins | 1 | 2013 | 323 | 0.020 |
Why?
|
| Propanolamines | 1 | 2012 | 70 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 337 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2012 | 84 | 0.020 |
Why?
|
| Cats | 1 | 2012 | 292 | 0.020 |
Why?
|
| Aorta | 1 | 2013 | 316 | 0.020 |
Why?
|
| Furans | 1 | 2011 | 27 | 0.020 |
Why?
|
| Binding Sites | 2 | 2003 | 631 | 0.020 |
Why?
|
| Carbamates | 1 | 2011 | 41 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 329 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2012 | 184 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2012 | 95 | 0.020 |
Why?
|
| Cell Cycle Proteins | 2 | 2003 | 230 | 0.020 |
Why?
|
| Mitochondria, Liver | 1 | 2012 | 148 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2012 | 189 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2011 | 152 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2015 | 1692 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 567 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 954 | 0.020 |
Why?
|
| Inactivation, Metabolic | 1 | 2010 | 28 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2013 | 705 | 0.020 |
Why?
|
| Aripiprazole | 1 | 2010 | 43 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 1465 | 0.020 |
Why?
|
| Quinolones | 1 | 2010 | 60 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 219 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 4848 | 0.020 |
Why?
|
| Methylphenidate | 1 | 2010 | 97 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 700 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2012 | 706 | 0.020 |
Why?
|
| Myosin Type II | 1 | 2008 | 2 | 0.020 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2008 | 13 | 0.020 |
Why?
|
| Myosin Light Chains | 1 | 2008 | 18 | 0.020 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2008 | 8 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2008 | 32 | 0.020 |
Why?
|
| Cell Shape | 1 | 2008 | 37 | 0.020 |
Why?
|
| Adherens Junctions | 1 | 2008 | 13 | 0.020 |
Why?
|
| Focal Adhesions | 1 | 2008 | 25 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 122 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2010 | 221 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2010 | 189 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 2010 | 247 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 5717 | 0.020 |
Why?
|
| Kidney | 1 | 2012 | 945 | 0.020 |
Why?
|
| Heart | 1 | 2012 | 850 | 0.020 |
Why?
|
| Proprotein Convertases | 1 | 2006 | 8 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 1293 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2008 | 324 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2006 | 60 | 0.020 |
Why?
|
| Metalloendopeptidases | 1 | 2006 | 67 | 0.020 |
Why?
|
| Catalysis | 1 | 2006 | 123 | 0.020 |
Why?
|
| Actins | 1 | 2008 | 249 | 0.020 |
Why?
|
| Oocytes | 1 | 2006 | 57 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2006 | 85 | 0.020 |
Why?
|
| Guanine Nucleotides | 1 | 2006 | 12 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 710 | 0.020 |
Why?
|
| Swine | 1 | 2008 | 672 | 0.020 |
Why?
|
| Indoles | 1 | 2007 | 146 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2007 | 765 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2006 | 123 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2004 | 48 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 2003 | 20 | 0.010 |
Why?
|
| Receptors, Serotonin, 5-HT1 | 1 | 2003 | 12 | 0.010 |
Why?
|
| Baculoviridae | 1 | 2003 | 14 | 0.010 |
Why?
|
| Biotinylation | 1 | 2003 | 27 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2003 | 12 | 0.010 |
Why?
|
| Microscopy, Video | 1 | 2003 | 27 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2003 | 92 | 0.010 |
Why?
|
| Cell-Free System | 1 | 2003 | 43 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 88 | 0.010 |
Why?
|
| Cytosol | 1 | 2003 | 123 | 0.010 |
Why?
|
| Serotonin | 1 | 2003 | 144 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 302 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2003 | 254 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2003 | 282 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2003 | 44 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 357 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 14862 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 2003 | 112 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2003 | 312 | 0.010 |
Why?
|
| Self Administration | 1 | 2004 | 419 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2003 | 284 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2003 | 312 | 0.010 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2004 | 435 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 21147 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 21403 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 4655 | 0.010 |
Why?
|
| Cocaine | 1 | 2004 | 555 | 0.010 |
Why?
|
| Brain | 1 | 2003 | 2176 | 0.010 |
Why?
|